Pseudotumor cerebri associated with cyclosporine use in severe atopic dermatitis

Pediatr Dermatol. 2015 Mar-Apr;32(2):237-9. doi: 10.1111/pde.12273. Epub 2013 Dec 13.

Abstract

Cyclosporine use can cause neurologic complications in 0.5% to 35% of cases, although the appearance of pseudotumor cerebri (PC) is exceptional. PC secondary to the use of cyclosporine is described mainly in individuals who have received a bone marrow transplant. We report the first case, to our knowledge, of PC secondary to the use of cyclosporine in a child with severe atopic dermatitis, with satisfactory resolution and without vision sequelae.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Child
  • Cyclosporine / adverse effects*
  • Cyclosporine / therapeutic use
  • Dermatitis, Atopic / diagnosis
  • Dermatitis, Atopic / drug therapy*
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Pseudotumor Cerebri / chemically induced*
  • Pseudotumor Cerebri / physiopathology
  • Risk Assessment
  • Severity of Illness Index
  • Time Factors

Substances

  • Immunosuppressive Agents
  • Cyclosporine